Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05442203 · ClinicalTrials.gov registry record · NA

Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease

A NA study of Atrial Fibrillation and Structural Heart Disease, sponsored by Tempus AI.

Active
Registry status
NA
Development phase
1,000
Enrollment target
3
Study locations

NCT05442203 is a NA study of Atrial Fibrillation and Structural Heart Disease that is active but no longer recruiting, run by Tempus AI. The registered enrollment target is 1,000 participants, below the 2,992-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (67% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05442203, a NA study of Atrial Fibrillation and Structural Heart Disease, is active but no longer recruiting, sponsored by Tempus AI.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
3
Study locations

Study Summary

Atrial fibrillation is an abnormal beating of the heart that can lead to stroke or heart failure. Structural heart diseases are conditions that affect the heart valves or heart muscle and can cause permanent heart damage if left untreated. Sometimes people have atrial fibrillation or structural heart disease and do not know it. The purpose of this study is to evaluate two devices that can predict who has or may develop atrial fibrillation or structural heart disease based on the results of an electrocardiogram.

Conditions Studied

Atrial Fibrillation Structural Heart Disease

Interventions

  • DEVICE Zio Patch Monitor
  • DEVICE Echocardiogram

Study Locations (3)

Michigan

  • Corewell Health - Grand Rapids

Ohio

  • TriHealth - Cincinnati

Pennsylvania

  • Geisinger Medical Center - Danville

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2022-09-07
Est. Completion 2025-07
Phase NA

Sponsor

Tempus AI

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05442203

The ClinicalTrials.gov registry entry for NCT05442203 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,992-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (67% lower). The listed sponsor is Tempus AI, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Zio Patch Monitor is the first listed.

NCT05442203 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Michigan, Ohio, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05442203 about?

NCT05442203 is a clinical study titled "Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease". Atrial fibrillation is an abnormal beating of the heart that can lead to stroke or heart failure. Structural heart diseases are conditions that affect the heart valves or heart muscle and can cause permanent heart damage if left untreated. Sometimes people have atrial fibrillation or structural hear...

What is the current status of trial NCT05442203?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2022-09-07. Estimated completion is 2025-07.

What conditions does trial NCT05442203 study?

This clinical trial studies the following conditions: Atrial Fibrillation, Structural Heart Disease.

What interventions are being tested in trial NCT05442203?

The interventions under investigation include: Zio Patch Monitor (DEVICE), Echocardiogram (DEVICE).

Who is sponsoring clinical trial NCT05442203?

This trial is sponsored by Tempus AI, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05442203 being conducted?

This trial has 3 study locations across Michigan, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Structural Heart Disease

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.